Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Motor Activity 249Breast Neoplasms 136Neoplasms 108Prostatic Neoplasms 35Fatigue 35Obesity 25Lung Neoplasms 24Colorectal Neoplasms 24Polycystic Ovary Syndrome 17Colonic Neoplasms 16Ovarian Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 11Lymphoma 11Lymphedema 11Hematologic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Weight Loss 10Rectal Neoplasms 10Multiple Myeloma 10Head and Neck Neoplasms 10Leukemia 9Cardiotoxicity 9Insulin Resistance 8Brain Neoplasms 8Stomach Neoplasms 7Peripheral Nervous System Diseases 7Overweight 6Esophageal Neoplasms 6Cognitive Dysfunction 6

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Exercise × Clear all
NCT07548476 2026-05-04

ACE

Dana-Farber Cancer Institute

Phase NA Not yet recruiting
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Peripheral Nervous System Diseases

NCT05715684 2023-03-22

Prehab

Dana-Farber Cancer Institute

Phase NA Recruiting
25 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT01840137 2019-08-08

Trial of Prehabilitation in Vulnerable Patients Undergoing Cystectomy for Bladder Cancer

University of Michigan

Phase NA Completed
53 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02716623 2019-07-15

DEAL

University of Kansas Medical Center

Phase NA Completed
5 enrolled
Genitourinary

Urinary Bladder Neoplasms, Diabetes Mellitus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡